Fecal microbiota transplantation with ruxolitinib as a treatment modality for steroid‐refractory/dependent acute, gastrointestinal graft‐versus‐host disease: A case series

Fecal microbiota transplantation with ruxolitinib as a treatment modality for steroid‐refractory/dependent acute, gastrointestinal graft‐versus‐host disease: A case series

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hematology 2021-12, Vol.96 (12), p.E461-E463
Hauptverfasser: Biliński, Jarosław, Jasiński, Marcin, Tomaszewska, Agnieszka, Lis, Karol, Kacprzyk, Piotr, Chmielewska, Lidia, Karakulska‐Prystupiuk, Ewa, Mullish, Benjamin H., Basak, Grzegorz W.
Format: Artikel
Sprache:eng
Schlagworte:
Acute Disease
Aged
Fecal Microbiota Transplantation
Fecal microflora
Female
Graft vs Host Disease - therapy
Humans
Inhibitor drugs
Janus Kinases - antagonists & inhibitors
Male
Microbiota
Middle Aged
Nitriles - therapeutic use
Protein Kinase Inhibitors - therapeutic use
Pyrazoles - therapeutic use
Pyrimidines - therapeutic use
Steroids - therapeutic use
Transplantation
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0361-8609
1096-8652
DOI:10.1002/ajh.26365